The COB can't convert much of his debt because there are only 295 million shares on the shelf. That means you think the company will either increase the A/S or do a reverse split. Which do you believe?
You believe that Staelin will convert his convertible debt into stock. In contrast, srinsocal insists that the company will pay off the Staelin and Whelan loans instead of converting them. Interesting. Whom to believe -- you or srinsocal? What logic are you offering?
Regardless, you're missing the point of my post. Read it literally.
1. I said the COB owns zero shares. Do you disagree?
2. I said that the COB converted shares in the past and dumped them all -- over a BILLION shares. Do you disagree?
If you agree that Staelin dumped over a billion conversion shares in the past, WHY do you believe he wouldn't do that again? When he dumped those shares in the past, BIEL had upcoming catalysts and positive potential like recent/upcoming FDA clearances, clinical trials, distribution deals, and higher revenues. Staelin dumped into those catalysts, but you think that when he converts in the future, HE WILL HOLD? Why do you think he will hold this time?
I remember when Kelly Whelan was asked why she didn't on more stock. Her reply was, paraphrased, that she potentially owns enough stock through possible conversions. You're offering the same excuse now for Staelin. Considering (a) the dumping history of these two (Whelan also dumped a billion conversion shares), (b) the current A/S and O/S, and (c) the current stock price, I find this to be laughable bullshit. But let's hear your defense of this argument.
Market Data 
Markets 
AI
